Rare diseases
Investigational molecules
Locations
Back to France458 clinical trials in Amiens, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceStudy Comparing Standard Care and Targeted Treatment with Telemonitoring for Ulcerative Colitis Patients Using Adalimumab
FranceStudy on the Effectiveness of Baricitinib for Patients with Refractory Non-Infectious Uveitis
FranceStudy on the Safety and Effects of Navitoclax and Ruxolitinib for Patients with Myelofibrosis and Myeloproliferative Neoplasms
FranceStudy on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More
FranceStudy of Tamibarotene and Azacitidine Treatment in Newly Diagnosed Adults with RARA-positive Higher-risk Myelodysplastic Syndrome (MDS)
FranceStudy of palbociclib with hormone therapy guided by ESR1 mutation monitoring in patients with ER-positive, HER2-negative metastatic breast cancer
FranceStudy on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease
FranceStudy on the Effectiveness and Safety of BGY-1601-VT for Women with Acute Vaginal Infections, Including Bacterial Vaginosis and Yeast Infections
FranceStudy on the Long-Term Safety of ND0612 (Carbidopa, Levodopa) Infusion for Patients with Advanced Parkinson's Disease
FranceLong-term study of upadacitinib tablets for adults with Crohn's disease
FranceFranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on head and neck cancers and multiple myeloma treatments. Studies include novel combination therapies and targeted approaches for improved patient outcomes.
Research emphasizes personalized treatment approaches combining immunotherapy with conventional treatments.
Comprehensive research into heart failure prevention and chronic kidney disease management, with focus on innovative therapeutic combinations.
Trials exploring new drug combinations and surgical interventions for improved cardiovascular outcomes.
Studies investigating treatments for Crohn's Disease and other inflammatory conditions, including innovative microbiota-based approaches.
Focus on developing targeted therapies and investigating treatment discontinuation strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
